We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Motif Bio Plc | LSE:MTFB | London | Ordinary Share | GB00BVVT4H71 | ORD 0.01P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.50 | 0.40 | 0.55 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMMTFB
RNS Number : 1724W
Motif Bio PLC
07 February 2017
Motif Bio plc
("Motif Bio" or the "Company")
Notification and public disclosure of transactions by PDMR and persons closely associated with them
Motif Bio plc (AIM: MTFB), the clinical stage biopharmaceutical company specialising in developing novel antibiotics, announces that on 6 February 2017 it was notified that Amphion Innovations plc ("Amphion") had pledged an additional 14,500,000 ordinary shares of 1 penny each in the capital of Motif Bio as security to a draw-down of an additional tranche of Amphion's loan facility (the "Share Pledge"). In total, Amphion has pledged 42,461,625 ordinary shares in the Company in relation to the Share Pledge. As a result of the Share Pledge, Amphion will transfer legal title to but will retain the beneficial interest in these pledged ordinary shares. Richard Morgan and Robert Bertoldi, non-executive Chairman and executive director of the Company respectively, are also directors of Amphion (the "Amphion Directors"). Amphion is therefore a "Person Closely Associated" with the Amphion Directors under the Market Abuse Regulation. The Share Pledge does not change the number of ordinary shares of the Company in issue.
The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.
1 Details of the person discharging managerial responsibilities/person closely associated ------- --------------------------------------------------------------- a) Name Amphion Innovations Plc ------- ------------------------------- ------------------------------ 2 Reason for the notification ------- --------------------------------------------------------------- Person Closely Associated a) Position/status with PDMRs of Motif Bio Plc (Robert Bertoldi and Richard Morgan) ------- ------------------------------- ------------------------------ b) Initial notification/Amendment Initial Notification ------- ------------------------------- ------------------------------ 3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ------- --------------------------------------------------------------- a) Name Motif Bio Plc ------- ------------------------------- ------------------------------ b) LEI 54930080DN00QTIUUU84 ------- ------------------------------- ------------------------------ 4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted ------- --------------------------------------------------------------- a) Description of the Ordinary Shares financial instrument, type of instrument ISIN GB00BVVT4H71 Identification code ------- ------------------------------- ------------------------------ b) Nature of the transaction Transfer of the legal but not beneficial interest in 14,500,000 Ordinary Shares by way of a pledge for a loan ------- ------------------------------- ------------------------------ c) Price(s) and volume(s) Price(s) Volume(s) ---------- ----------- N/A 14,500,000 ---------- ----------- ------- ------------------------------- ------------------------------ d) Aggregated information Price(s) Volume(s) ---------- ----------- N/A 14,500,000 ---------- ----------- ------- ------------------------------- ------------------------------ e) Date of the transaction 6 February 2017 ------- ------------------------------- ------------------------------ f) Place of the transaction N/A ------- ------------------------------- ------------------------------
For further information please contact:
Motif Bio plc info@motifbio.com Graham Lumsden (Chief Executive Officer) Zeus Capital Limited (NOMAD & BROKER) +44 (0)20 3829 5000 Phil Walker/Giles Balleny Dominic Wilson Northland Capital Partners Limited (BROKER) +44 (0)203 861 6600 Patrick Claridge/ David Hignell John Howes/ Rob Rees (Broking) Walbrook PR Ltd. (FINANCIAL +44 (0) 20 7933 8780 or PR & IR) motifbio@walbrookpr.com Paul McManus Mob: +44 (0)7980 541 893 Mike Wort Mob: +44 (0)7900 608 002 MC Services AG (EUROPEAN IR) +49 (0)89 210 2280 Raimund Gabriel
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHEAAAKEFLXEAF
(END) Dow Jones Newswires
February 07, 2017 02:02 ET (07:02 GMT)
1 Year Motif Bio Chart |
1 Month Motif Bio Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions